NYSE:BMEZ BlackRock Health Sciences Term Trust (BMEZ) Stock Price, News & Analysis $14.08 -0.13 (-0.88%) Closing price 05/7/2026 03:59 PM EasternExtended Trading$14.08 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About BlackRock Health Sciences Term Trust Stock (NYSE:BMEZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BMEZ alerts:Sign Up Key Stats Today's Range$14.04▼$14.2650-Day Range$13.77▼$15.0852-Week Range$13.67▼$15.80Volume147,526 shsAverage Volume254,077 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield10.93%Price TargetN/AConsensus RatingN/A Company Overview BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion. The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services. Utilizing BlackRock’s fundamental research platform, BMEZ takes both long and, when appropriate, short positions to manage risk and potentially enhance returns. The trust may also employ leverage and derivatives to pursue its investment objectives, subject to its board-approved guidelines. As a product of BlackRock, Inc., the world’s largest asset manager, BMEZ benefits from the firm’s extensive health sciences research capabilities and global distribution network. Portfolio management is led by a team of seasoned health sciences specialists at BlackRock Advisors, who leverage the firm’s proprietary analytics and risk management infrastructure. Oversight is provided by an independent board of trustees, ensuring that the trust adheres to its stated strategy and governance standards.AI Generated. May Contain Errors. Read More Receive BMEZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BlackRock Health Sciences Term Trust and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMEZ Stock News HeadlinesBlackRock Health Sciences Term TrustApril 5, 2026 | money.usnews.comBMEZ: Sell, Distributions Down 34% And UndercoveredMarch 22, 2026 | seekingalpha.comSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses an emerging potential $10 trillion technology backed by Elon Musk and Sam Altman. This breakthrough could completely replace our need for foreign oil - and send one small group of stocks soaring in the process. | Altimetry (Ad)Forget Software Stocks: This 8.8% Dividend Is The Real AI BargainMarch 4, 2026 | forbes.comCertain BlackRock Closed-End Funds Announce Estimated Sources of DistributionsFebruary 27, 2026 | businesswire.comBMEZ: Deep Discount Once Again Makes It An Interesting PlayJanuary 3, 2026 | seekingalpha.comCertain BlackRock Closed-End Funds Announce Estimated Sources of DistributionsNovember 28, 2025 | businesswire.comBMEZ: NAV Decline Continues And Underperforms PeersNovember 28, 2025 | seekingalpha.comSee More Headlines BMEZ Stock Analysis - Frequently Asked Questions How have BMEZ shares performed this year? BlackRock Health Sciences Term Trust's stock was trading at $15.0680 at the start of the year. Since then, BMEZ shares have decreased by 6.5% and is now trading at $14.0850. When did BlackRock Health Sciences Term Trust IPO? BlackRock Health Sciences Term Trust (BMEZ) raised $2.1 billion in an initial public offering on Wednesday, January 29th 2020. The company issued 105,000,000 shares at a price of $20.00 per share. Who are BlackRock Health Sciences Term Trust's major shareholders? BlackRock Health Sciences Term Trust's top institutional shareholders include Evolve Private Wealth LLC, Kestra Advisory Services LLC, Apollon Wealth Management LLC and TrueMark Investments LLC. Insiders that own company stock include Saba Capital Management, LP and Christopher Accettella. View institutional ownership trends. How do I buy shares of BlackRock Health Sciences Term Trust? Shares of BMEZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BlackRock Health Sciences Term Trust own? Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Term Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), PIMCO Dynamic Income Fund (PDI), DoubleLine Income Solutions Fund (DSL), Pimco Dynamic Income Opportunities Fund (PDO) and OneMain (OMF). Company Calendar Today5/07/2026Record date for 5/29 Dividend5/15/2026Ex-Dividend for 5/29 Dividend5/15/2026Dividend Payable5/29/2026Record date for 6/30 Dividend6/15/2026Ex-Dividend for 6/30 Dividend6/15/2026Dividend Payable6/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, BMEZ's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry - Sub-IndustryN/A Current SymbolNYSE:BMEZ CIK1785971 Webwww.blackrock.com Phone212-810-5300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$101.58 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:BMEZ) was last updated on 5/8/2026 by MarketBeat.com Staff. From Our PartnersMassive Data Leak Exposes 512,000-Line Code That Could Change Society Forever"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...Chaikin Analytics | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | SponsoredWhy I flew on a tiny helicopter next to a potential nuclear bomb targetSatellite Confirms: Elon Musk Activating Strange 'Dark Energy' Across U.S. South Confirmed by satellites 30...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHey, Have You Claimed Your Rebate Check??The U.S. has already collected $195 billion in tariff revenue this year, with projections reaching $400 billio...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BlackRock Health Sciences Term Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share BlackRock Health Sciences Term Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
